Thailand PGT CMS

博客

  • PGT for Advanced Maternal Age in Thailand: What It Can and Cannot Tell You

    Preimplantation genetic testing (PGT) is a laboratory step that can be added to an IVF cycle to examine embryos before transfer. For patients over 35, the main reason PGT is discussed is that the chance of an embryo having the wrong number of chromosomes — called aneuploidy — tends to rise with age. PGT-A is the version most often raised in this context. It is not a guarantee of pregnancy or a healthy child, and it is not automatically right for everyone. In Thailand, as elsewhere, whether PGT is offered and which type is used depends on your history, your embryos and the clinic’s own protocols.

    At a glance

    • Age matters mainly for PGT-A, which looks at chromosome number. The likelihood of aneuploidy increases with maternal age, but age alone does not decide whether you should test.
    • PGT-M and PGT-SR are different. They are used when there is a known inherited condition or a known structural chromosome rearrangement, not simply because of age.
    • PGT is a screening or diagnostic tool, not a treatment. It cannot create healthy embryos or fix an embryo.
    • Results can be uncertain. Some embryos give a “no result” or “mosaic” outcome, and clinics differ in how they handle these.
    • Costs, legal rules and paperwork vary. Confirm all of these directly with the clinic and relevant authorities before you travel.

    Why age is linked to PGT-A discussions

    Eggs are formed before birth and age with the person. Over time, the machinery that separates chromosomes during cell division becomes less reliable, so an embryo created from an older egg is more likely to have an extra or missing chromosome. This is a biological tendency, not a personal failing, and it does not mean every embryo will be affected.

    Because aneuploidy is more common with age, some clinics are more likely to discuss PGT-A with patients over 35, especially those with previous IVF cycles that did not lead to a live birth, or previous miscarriages. However, guidance from professional bodies does not recommend PGT-A for every patient based on age alone. It is usually a shared decision that weighs the possible benefits against the costs, the extra laboratory steps, and the possibility that no embryo will be available to transfer after testing.

    What PGT-A, PGT-M and PGT-SR actually look at

    These three tests are often grouped together, but they answer different questions.

    Test Main question Typical reason it is discussed
    PGT-A Does this embryo have the expected number of chromosomes? Age-related risk of aneuploidy, recurrent miscarriage, repeated unsuccessful transfers
    PGT-M Does this embryo carry a specific gene variant linked to a known condition? A known inherited condition in the family or in one or both parents
    PGT-SR Does this embryo have an unbalanced form of a known chromosome rearrangement? A known structural rearrangement such as a translocation in a parent

    PGT-A is the type most connected to age. PGT-M and PGT-SR are usually considered because of a specific genetic finding, not because of age. A clinic may sometimes combine tests, but the reasons and the laboratory work are different.

    How Thai clinics may frame PGT-A for patients over 35

    Thailand has a well-developed IVF sector, and many clinics follow international laboratory standards. Even so, individual clinics set their own internal policies. When age is the main reason PGT-A is being discussed, you may hear some of the following framings. Treat them as conversation points, not as rules that apply everywhere.

    • “We usually discuss PGT-A from a certain age.” Some clinics use an age threshold as a prompt for discussion, but the decision should still be individual.
    • “Testing may help us choose which embryo to transfer first.” This is a common rationale, but it depends on how many embryos you have and whether any give a clear result.
    • “Testing may reduce the chance of transferring an embryo with an abnormal chromosome number.” This is plausible, but it does not remove all risk, and it does not guarantee a pregnancy.
    • “We may recommend not testing if you have very few embryos.” Some clinics raise this because testing a small number of embryos can leave nothing to transfer.
    • “We may offer a fresh or frozen transfer plan.” PGT usually requires embryos to be biopsied and then frozen while results are awaited, but protocols vary.

    Because these are clinic-level practices, ask directly how the clinic decides, what its laboratory does, and what happens if results are unclear.

    What a PGT result can and cannot tell you

    A PGT result is information about the cells that were sampled, not a complete picture of the embryo or the future child.

    • Euploid: the expected number of chromosomes was seen in the sampled cells. This does not guarantee implantation, pregnancy or a healthy baby.
    • Aneuploid: an abnormal chromosome number was seen. This usually means the embryo is not recommended for transfer, but the clinic will explain what it found.
    • Mosaic: a mix of normal and abnormal cells was seen. Some clinics may consider transferring certain mosaic embryos after counselling; others may not. This is a clinic-specific and case-specific decision.
    • No result or inconclusive: the test could not give a clear answer. The clinic may offer re-biopsy, repeat testing or a different plan.

    PGT-A does not test for every possible genetic condition. It does not measure embryo quality in general. It does not predict intelligence, appearance or future health beyond the chromosomes examined. PGT-M and PGT-SR are more targeted, and their meaning depends on the specific condition or rearrangement being tested.

    Possible alternatives and additions to PGT

    PGT is one option among several. Depending on your situation, you and your clinician might also discuss:

    • IVF without PGT, with embryo selection based on standard laboratory grading.
    • Expectant management or further natural attempts, if that is medically appropriate for you.
    • Donor eggs, which changes the age-related chromosome risk profile because the eggs come from a younger donor. This is a significant decision with its own legal, ethical and emotional considerations.
    • Genetic counselling, especially if there is a known inherited condition or a history of recurrent miscarriage.
    • Additional testing during pregnancy, such as screening or diagnostic tests, which are separate from PGT.

    None of these is universally better. The right path depends on your medical history, your values and what is available to you.

    Practical questions to ask a clinic in Thailand

    Bring these questions to your consultation. Write down the answers so you can compare clinics fairly.

    1. Based on my age and history, why are you recommending or not recommending PGT-A?
    2. Which PGT type are you proposing, and what exactly will it test for?
    3. What proportion of embryos typically give a clear result in your laboratory, and what happens if mine do not?
    4. How do you handle mosaic results? Do you transfer them, and under what conditions?
    5. What are the total costs, including biopsy, testing, freezing, storage and any re-testing?
    6. What are the legal and consent requirements for international patients using PGT in Thailand?
    7. What documents do I need to bring, and how long should I plan to stay?
    8. Who will explain the results to me, and in what language?
    9. What are my options if no embryos are suitable for transfer after testing?
    10. Can I speak with a genetic counsellor if needed?

    Planning checklist for international patients

    • Gather your medical records, including previous IVF cycles, miscarriage history and any genetic test results.
    • Ask the clinic for a written summary of its PGT approach, costs and consent process.
    • Confirm visa, travel and accommodation requirements with the relevant authorities and the clinic; rules can change.
    • Ask how results will be communicated and what follow-up is included.
    • Consider independent genetic counselling before you decide, especially for PGT-M or PGT-SR.
    • Plan for uncertainty: testing may reduce the number of embryos available for transfer.

    Where to read more

    For a broader overview of PGT in Thailand, see our PGT in Thailand guide. Our patient guides cover related planning topics, and the FAQ section answers common questions about testing, travel and clinic communication.

    Frequently asked questions

    Does every IVF patient over 35 need PGT-A in Thailand?

    No. Age increases the chance of aneuploidy, but professional guidance does not recommend PGT-A for everyone based on age alone. Whether it is offered depends on your history, the number of embryos you have, and the clinic's protocols. It is usually a shared decision after discussing benefits, costs and limitations.

    What is the difference between PGT-A, PGT-M and PGT-SR?

    PGT-A looks at the number of chromosomes and is the type most often discussed in relation to age. PGT-M looks for a specific inherited condition, and PGT-SR looks for a known structural chromosome rearrangement. PGT-M and PGT-SR are usually considered because of a known genetic finding, not because of age.

    Can PGT guarantee a healthy baby?

    No. PGT can provide information about the cells sampled from an embryo, but it cannot guarantee implantation, pregnancy, live birth or a child without any health condition. It does not test for every possible genetic or health issue, and some results are uncertain.

    What happens if my PGT result is mosaic or inconclusive?

    A mosaic result means a mix of normal and abnormal cells was seen, and an inconclusive result means the test could not give a clear answer. Clinics differ in how they handle these situations. Some may consider transferring certain mosaic embryos after counselling, while others may not. Ask your clinic about its specific policy before you start.

    How should I compare clinics in Thailand for PGT?

    Ask each clinic the same questions: why it recommends or does not recommend PGT for your situation, what the total costs include, how it handles unclear results, what legal and consent steps apply to international patients, and how results will be explained. Compare the answers in writing rather than relying on general impressions.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • Mosaic Embryo Results in Thailand: What They Mean for International Patients

    A mosaic embryo result means the PGT sample showed a mixture of cells with typical chromosome patterns and cells with atypical patterns. It is not a simple positive or negative. Mosaicism exists on a spectrum, and the laboratory report usually describes the percentage of atypical cells and the type of chromosome change. Thai clinics vary in how they counsel international patients about these results. Some may discuss transfer, some may recommend further review, and some may suggest a different embryo. The right next step depends on your full clinical picture, the specific mosaic finding, and the clinic’s own laboratory and counseling protocols. This guide explains the categories and the questions that help you make an informed decision.

    At a glance

    • A mosaic result is a spectrum finding, not a yes-or-no diagnosis.
    • Reports usually include the percentage of atypical cells and whether the change is a full chromosome gain or loss, a segment, or a mix.
    • Lower-level mosaicism is often discussed differently from higher-level mosaicism, but thresholds and terminology can differ between laboratories.
    • Thai clinics may have different counseling approaches, so ask how your clinic classifies and reports mosaicism.
    • Transfer decisions are individual and depend on your history, the specific embryo, and what your clinic can support.
    • No PGT result can guarantee a healthy pregnancy or child.

    What a mosaic PGT result actually means

    Preimplantation genetic testing for aneuploidy (PGT-A) examines a small sample of cells from an embryo. In a typical result, the report describes whether the tested cells showed a normal number of chromosomes (euploid) or an abnormal number (aneuploid). A mosaic result falls between these two categories: some tested cells appear euploid and some appear aneuploid.

    Mosaicism can arise during early embryo development. It does not necessarily mean the whole embryo is affected, and it does not predict with certainty how the embryo will develop. The laboratory report is a snapshot from a small sample, not a complete map of every cell.

    PGT-M (for monogenic conditions) and PGT-SR (for structural rearrangements) are different tests with different purposes. A mosaic finding on a PGT-A report is not the same as a PGT-M or PGT-SR result. If you are unsure which test was used, ask your clinic to clarify before interpreting the result.

    How mosaic results are classified

    Laboratories use different systems, but most mosaic reports include some combination of the following information. The exact terms and thresholds can vary, so always ask your clinic to explain the specific language on your report.

    Report element What it usually describes Why it matters for counseling
    Mosaic level or percentage The estimated proportion of cells with an atypical chromosome pattern Lower and higher levels may be discussed differently, but there is no universal cutoff that applies to every clinic or every chromosome
    Chromosome involved Which chromosome or chromosomes showed the mosaic finding Some chromosomes are associated with different counseling considerations than others
    Type of change Full chromosome gain or loss, a segmental change, or a combination Segmental and full-chromosome findings may be reported and interpreted differently
    Number of cells analyzed How many cells were examined in the sample A small sample size can affect how confidently a mosaic result can be interpreted
    Laboratory comments Any notes about the finding, limitations, or recommendations These comments often contain the most practical guidance for your clinic

    Some laboratories use categories such as low-level, high-level, or a specific percentage range. Others may report a mosaic finding without a precise percentage. If your report uses a term you do not recognize, ask your clinic for a plain-language explanation.

    Why Thai clinics may counsel mosaic results differently

    Thailand has many IVF clinics, and each may have its own approach to mosaic embryo counseling. Differences can include:

    • Which laboratory performs the PGT testing and how that laboratory defines and reports mosaicism.
    • Whether the clinic has an internal policy on transferring mosaic embryos and at what mosaic level.
    • How the clinic weighs the mosaic finding against other factors such as your age, embryo quality, and previous cycles.
    • Whether the clinic offers additional counseling, genetic counseling, or a review of the raw data.
    • How the clinic communicates uncertainty and what it recommends when evidence is limited.

    Because these approaches vary, a mosaic result that one clinic describes as transferable may be described differently at another. This does not necessarily mean one clinic is right and another is wrong. It often reflects different laboratory protocols, different interpretations of the same evidence, and different clinical policies.

    For international patients, it can help to ask for the clinic’s written policy on mosaic embryos before you travel or before you make a transfer decision. If the clinic does not have a written policy, ask how the decision is typically made and who is involved.

    What a mosaic result does not tell you

    A mosaic PGT result cannot tell you with certainty:

    • Whether the embryo will implant.
    • Whether a pregnancy would continue.
    • Whether a child would be born healthy.
    • Whether the mosaic finding is confined to the placenta or affects the fetus.
    • Whether another embryo from the same cycle would have a different result.

    PGT is a screening test, not a diagnostic test for every cell of the embryo. It can reduce uncertainty in some situations, but it cannot eliminate it. This is one reason why mosaic counseling focuses on probabilities, trade-offs, and your individual priorities rather than guarantees.

    Questions to ask your Thai clinic about a mosaic result

    These questions can help you understand your clinic’s approach and make a more informed decision. You may want to ask them in writing so you have a record of the answers.

    1. Which laboratory performed the PGT, and how does that laboratory define and report mosaicism?
    2. What is the exact mosaic level or percentage on my report, and what does that mean in plain language?
    3. Which chromosome or chromosomes are involved, and does that change the counseling?
    4. How many cells were analyzed, and how confident is the laboratory in the result?
    5. Does the clinic have a policy or guideline for transferring mosaic embryos? If so, what is it?
    6. What are the possible next steps if we decide not to transfer this embryo?
    7. Are there additional tests or counseling options that could provide more information?
    8. How does this mosaic result fit with my overall history and other embryos from this cycle?
    9. What would you recommend if this were your own embryo, and why?
    10. What follow-up or monitoring would you recommend if we proceed with transfer?

    If you are working with a clinic in Thailand from another country, also ask how communication will be handled, who your main contact will be, and how you will receive updated reports or recommendations.

    Decision points for international patients

    After receiving a mosaic result, you may face several decisions. There is rarely a single correct path, and the best choice depends on your circumstances.

    Transfer the mosaic embryo

    Some patients and clinics decide to transfer a mosaic embryo after weighing the alternatives. This decision may be influenced by the mosaic level, the chromosome involved, the number of other available embryos, your age, your history, and your willingness to accept uncertainty. If you choose this path, ask your clinic what monitoring or follow-up they recommend.

    Choose another embryo

    If you have other embryos that are not mosaic, you and your clinic may discuss prioritizing those first. This is a common consideration, but it depends on how many embryos you have and their individual results.

    Consider another cycle

    Some patients consider another IVF cycle to try to obtain additional embryos. This is a significant decision with its own medical, emotional, and practical considerations. Ask your clinic how another cycle might be approached and what factors would be considered.

    Seek a second opinion

    If you are unsure about your clinic’s interpretation, you may wish to seek a second opinion from another qualified professional. A second opinion can help you understand the range of views on mosaic embryos, but it may also reflect the same uncertainties. Ask for the raw data or a detailed report if you want another professional to review the finding.

    What to confirm before you travel or decide

    If you are an international patient planning to travel to Thailand for a transfer or consultation, confirm the following with your clinic:

    • How the clinic will communicate the mosaic result and any recommendations.
    • Whether a consultation can be done remotely before travel.
    • What documents or records the clinic needs from you, and how to send them securely.
    • What the clinic’s policy is on mosaic embryo transfer, including any consent process.
    • What follow-up care is available after transfer, and how it can be coordinated with your home clinic.
    • What costs are associated with the consultation, transfer, and any additional testing, and how payment is handled.
    • Whether there are any legal or regulatory considerations for your situation, and who can confirm them.

    Because policies and requirements can change, always confirm current details directly with the clinic and, where relevant, with the appropriate authorities. This guide does not provide legal, financial, or medical advice for your individual situation.

    Next steps

    Receiving a mosaic result can feel uncertain. A practical next step is to gather clear information from your clinic and write down your questions before your next conversation. Ask for the specific details of your report, the clinic’s policy, and the reasoning behind any recommendation. If you are considering transfer, ask what follow-up would be recommended. If you are considering another option, ask what that process would involve. You do not have to decide immediately, and you can take time to review the information with people you trust.

    For more general information about PGT in Thailand, see our PGT in Thailand guide. You can also browse our guides and FAQ for related topics.

    Frequently asked questions

    Does a mosaic embryo result mean the embryo is abnormal?

    A mosaic result means the tested sample contained a mix of cells with typical and atypical chromosome patterns. It is not the same as a uniformly abnormal result, and it does not predict with certainty how the embryo will develop. The meaning depends on the specific finding, the laboratory's definitions, and your clinic's interpretation.

    Can a mosaic embryo be transferred in Thailand?

    Some Thai clinics may offer transfer of mosaic embryos, while others may not, and policies can vary. There is no single national rule that applies to every clinic or every mosaic finding. Ask your clinic directly about its policy, how it makes transfer decisions, and what consent or counseling it requires.

    What is the difference between low-level and high-level mosaicism?

    Laboratories may use different thresholds to describe mosaic levels. In general, a lower percentage of atypical cells may be discussed differently from a higher percentage, but there is no universal cutoff that applies to all chromosomes or all clinics. Ask your clinic to explain the specific level on your report and how it affects their counseling.

    Should I get a second opinion on my mosaic result?

    A second opinion can be helpful if you want another professional's perspective on the report or the clinic's recommendation. It may not resolve all uncertainty, because mosaic interpretation involves judgment and varies between laboratories and clinics. If you seek a second opinion, ask your clinic for the detailed report or raw data that the reviewer would need.

    Does a mosaic result affect future IVF cycles?

    A mosaic result in one embryo does not necessarily predict the results of a future cycle. Mosaicism can vary between embryos and between cycles. If you are considering another cycle, ask your clinic how they would approach it and what factors they would consider based on your history.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT Results Timeline in Thailand: How Long Results Take and How to Plan Travel

    PGT results in Thailand are not usually available on the same day as the biopsy. In a typical freeze-all cycle, embryos are cultured to a suitable stage, a small sample is taken, the sample is sent to a genetics laboratory, and the embryos are frozen while the laboratory processes the sample. The waiting period is often described in weeks rather than days, but the exact turnaround depends on the clinic, the laboratory, the type of PGT requested, shipping arrangements if relevant, and how the report is delivered. Ask your clinic for the expected report date, how it will be delivered, and whether it affects your transfer or travel plans.

    At a glance

    • PGT is usually done as part of a freeze-all cycle, so the embryo transfer is planned for a later cycle.
    • Turnaround time is best understood in stages: biopsy, laboratory processing, reporting, and clinical review.
    • International patients should treat the result date as a planning window, not a fixed appointment.
    • Ask your treating clinic for its own typical range and for what can delay a report.
    • Do not book rigid onward travel until the clinic confirms the next step.

    Why PGT results take time

    Preimplantation genetic testing involves several sequential steps, and each one adds time. First, the embryo must reach the stage at which a biopsy can be performed. That depends on embryo development, which is individual and cannot be guaranteed in advance. Second, the biopsy sample must be prepared and transported to the genetics laboratory. Third, the laboratory must process the sample and generate a report. Fourth, the treating clinic must review the report in the context of your cycle before discussing next steps with you.

    Because these steps are sequential, the total wait is not simply the laboratory’s processing time. A delay at any stage can move the expected result date. This is normal in IVF planning, and it is one reason clinics usually avoid promising a specific calendar date for results.

    The typical stages of the PGT timeline

    The table below describes the stages you can expect to discuss with your clinic. It deliberately does not include exact day counts, because those vary by provider, laboratory and case.

    Stage What happens What affects timing
    Embryo culture and biopsy Embryos are monitored and, if suitable, sampled Embryo development, clinic protocol, laboratory schedule
    Sample handling and transport The sample is prepared and sent to the genetics laboratory Laboratory arrangements, shipping or courier logistics, weekends and public holidays
    Laboratory processing The genetics laboratory analyses the sample and prepares a report Type of PGT requested, sample quality, laboratory workload, need for repeat analysis
    Report delivery and clinical review The report reaches your clinic and is reviewed by your care team Clinic review process, how results are communicated, time zone differences
    Planning the transfer cycle If you proceed, the clinic plans a frozen embryo transfer cycle Your availability, clinic schedule, travel arrangements, medical preparation

    Freeze-all and what it means for your timeline

    In a freeze-all cycle, embryos are frozen after biopsy rather than transferred fresh. This allows the genetics laboratory time to process the sample without the pressure of a fresh transfer window. For international patients, freeze-all has a practical consequence: the transfer is usually a separate trip or a separate phase of your stay, planned after the report is available and reviewed.

    Freeze-all does not mean the timeline is unlimited. Embryos are stored according to the clinic’s laboratory procedures, and you should ask how storage is managed, how long it is included, and what happens if your plans change. Those are administrative and clinical questions for your treating clinic, not general rules that apply everywhere.

    How long PGT results take in Thailand: what to ask

    Rather than relying on a general figure, ask your clinic for its own typical range and for the factors that can extend it. Useful questions include:

    • What is your usual turnaround range for the type of PGT I am considering?
    • Is the analysis performed in-house or at an external laboratory?
    • Does the estimate include weekends, public holidays or shipping time?
    • What are the most common reasons a report is delayed?
    • How will I be told the result, and who will explain what it means for my cycle?
    • If the report needs additional review or repeat analysis, how is that handled?

    These questions help you build a realistic window rather than a single date. They also clarify who is responsible for each step, which matters when you are coordinating care from another country.

    Planning travel around an uncertain result date

    International patients often want to know whether they can stay in Thailand for the whole process or whether they should return home and come back for the transfer. There is no single answer. It depends on your clinic’s protocol, your medical situation, how long you can stay, and how you prefer to manage uncertainty.

    A practical approach is to separate your trip into phases:

    1. Monitoring and retrieval phase: the appointments leading up to and including egg retrieval and, if applicable, embryo biopsy.
    2. Waiting phase: the period when the laboratory processes the sample. Some patients stay in Thailand; others return home.
    3. Transfer phase: a separate visit or stay planned after the report is reviewed and the clinic confirms you are ready to proceed.

    When you plan, avoid booking non-refundable onward travel or tightly connecting flights around the expected result date. Leave buffer time. Confirm with your clinic how much notice you will receive before the transfer cycle begins, and whether any preparation appointments can be done locally or remotely.

    What can make the timeline longer

    Several factors can extend the wait, and none of them necessarily indicate a problem:

    • Embryo development that does not reach the expected stage on the expected day.
    • Laboratory workload or scheduled closures.
    • Public holidays in Thailand or in the laboratory’s location.
    • Shipping or courier delays if the sample is sent to another facility.
    • A sample that requires additional processing or a repeat analysis.
    • Time needed for your clinic to review the report and contact you.

    Because these factors are individual, a responsible clinic will give you a range and explain what could change it, rather than guaranteeing a date.

    What PGT results do and do not tell you

    PGT is a laboratory test performed on a small sample of cells. It provides information that your clinician interprets alongside your medical history and the specifics of your cycle. It does not guarantee a pregnancy, a live birth or a healthy child, and it does not replace the clinical judgment of your treating team. This article does not interpret results, because interpretation depends on the type of PGT, the laboratory’s report and your individual circumstances.

    If you receive a report and have questions about what it means for you, those questions belong with your treating clinician or a qualified genetics professional, not with a general guide.

    Questions to ask before you commit to a timeline

    • What is your typical PGT turnaround range, and what is the longest it has recently taken?
    • Is the genetics laboratory on-site or external?
    • How are results communicated, and in what language?
    • What preparation is needed for a frozen embryo transfer cycle, and when does it start?
    • How much flexibility is there if my travel dates need to change?
    • What costs are associated with storage, repeat analysis or a second cycle, and when are they payable?
    • What documents or administrative steps should I prepare before travelling?

    Next-step checklist for international patients

    1. Ask your clinic for its own PGT turnaround range in writing.
    2. Ask which steps happen in Thailand and which, if any, happen elsewhere.
    3. Plan your trip in phases and keep the waiting phase flexible.
    4. Confirm how and when you will receive the report.
    5. Confirm the clinical review process and who will explain the result to you.
    6. Check travel documents, insurance and payment arrangements with the relevant authorities and your clinic.
    7. Build in buffer time before booking return or onward travel.

    For more context on the overall process, see PGT in Thailand, IVF in Thailand, treatment process and information for international patients.

    Frequently asked questions

    How long do PGT results take in Thailand?

    Turnaround varies by clinic, laboratory and type of PGT. Most clinics describe the wait in weeks rather than days, but the exact range should come from your treating clinic. Ask for its typical range and the factors that can extend it, such as laboratory workload, public holidays, shipping arrangements or the need for repeat analysis.

    Can I have a fresh embryo transfer while waiting for PGT results?

    PGT is usually performed as part of a freeze-all cycle, meaning embryos are frozen after biopsy and transferred in a later cycle once the report is available and reviewed. Whether a fresh transfer is possible in your case is a clinical decision for your treating team, not a general rule.

    Should I stay in Thailand while waiting for PGT results?

    There is no single answer. Some patients stay, while others return home and come back for the transfer. The right choice depends on your clinic's protocol, your medical situation, your budget and how you prefer to manage uncertainty. Discuss it with your clinic before booking travel.

    What can delay PGT results?

    Possible delays include embryo development that does not follow the expected schedule, laboratory workload or closures, public holidays, shipping or courier delays if the sample is sent elsewhere, a sample that needs additional processing, and the time your clinic needs to review the report and contact you.

    Do PGT results guarantee a successful pregnancy?

    No. PGT is a laboratory test that provides information your clinician interprets alongside your medical history. It does not guarantee pregnancy, live birth or child health. Questions about what a specific result means for you should be directed to your treating clinician or a qualified genetics professional.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT Cost in Thailand for International Patients: A Planning Guide

    PGT cost in Thailand for international patients is not a single fixed price. It is a bundle of laboratory, clinical and administrative components that vary by clinic, by the type of PGT you need, and by how many embryos are tested. Because no approved pricing evidence is available for this guide, we do not quote figures. Instead, this article explains the cost categories you will see, the questions that reveal what a quote really includes, and how to compare clinics fairly.

    At a glance

    • PGT pricing usually combines IVF cycle costs with separate genetic testing fees.
    • PGT-A, PGT-M and PGT-SR differ in laboratory work, so their pricing structures differ too.
    • Quotes may be per embryo, per batch, or bundled — always ask which.
    • Medication, monitoring, biopsy, shipping and follow-up can sit inside or outside the quote.
    • Currency, payment timing and refund rules matter as much as the headline number.

    Why PGT pricing is not one number

    Preimplantation genetic testing (PGT) is a laboratory step added to an IVF cycle. The IVF cycle itself involves ovarian stimulation, monitoring, egg retrieval, fertilisation and embryo culture. PGT then involves removing a small number of cells from an embryo, preparing those cells for analysis, running the genetic test, and interpreting the result. Each of these steps has its own cost driver.

    For international patients, there is also a planning layer: travel, accommodation, time away from work, and sometimes a need to stay longer than expected if the cycle timeline shifts. These are not clinic fees, but they belong in your budget.

    The main cost components

    When you receive a quote, try to map every line to one of the categories below. If a category is missing, ask whether it is included or billed separately.

    Category What it typically covers Why it varies
    IVF cycle Stimulation, monitoring, retrieval, fertilisation, embryo culture Protocol, number of visits, clinic setting
    Medication Stimulation and support drugs Dose, duration, brand, pharmacy
    Embryo biopsy Lab work to sample embryos Number of embryos, lab technique
    Genetic analysis PGT-A, PGT-M or PGT-SR laboratory testing Test type, number of embryos, platform
    Embryo storage Cryopreservation and storage of biopsied embryos Storage duration, number of embryos
    Administrative Consultations, coordination, records, translation Clinic policy, language support
    Travel and stay Flights, accommodation, local transport Origin, season, length of stay

    Some clinics present a single package price; others itemise. Neither approach is automatically better, but itemised quotes are easier to compare.

    PGT-A, PGT-M and PGT-SR: how the cost structure differs

    These three tests answer different questions, and their laboratory workflows are not identical.

    PGT-A

    PGT-A looks at chromosome number. It is often priced per embryo or in batches, because the laboratory work scales with the number of embryos tested. Ask whether the price changes if fewer embryos reach biopsy than expected.

    PGT-M

    PGT-M is used when a specific inherited condition is known in the family. It usually requires preparatory work before the IVF cycle, such as building a genetic probe or validating markers. That preparatory phase can be a separate fee, and it may need to be completed before stimulation begins. Because the preparation is case-specific, PGT-M quotes are often custom rather than published.

    PGT-SR

    PGT-SR relates to structural chromosome rearrangements. Like PGT-M, it may need custom laboratory setup, so the cost structure can resemble PGT-M more than PGT-A. Ask whether the clinic performs this in-house or sends samples to a partner laboratory, and how that affects both cost and timeline.

    What can change the final amount

    • Number of embryos tested: more embryos usually means more laboratory work.
    • Test type: PGT-M and PGT-SR often involve custom preparation.
    • Cycle outcome: if no embryos reach biopsy, testing fees may or may not be charged.
    • Repeat testing: inconclusive results may require re-analysis, which can carry an extra fee.
    • Storage duration: storage is often billed periodically.
    • Additional procedures: any extra clinical step is usually billed separately.
    • Exchange rate and payment method: international transfers and card fees can add to your total.

    How to compare quotes from different clinics

    Comparing headline numbers alone can be misleading. Use the same checklist for every clinic so you compare like with like.

    1. Ask for a written quote that separates IVF, biopsy, genetic analysis, storage and administrative fees.
    2. Confirm whether the genetic testing price is per embryo, per batch, or a flat package.
    3. Ask what happens financially if fewer embryos are available than planned.
    4. Ask whether preparatory work for PGT-M or PGT-SR is included or billed separately.
    5. Confirm the currency, the exchange-rate policy, and when payments are due.
    6. Ask about refund or credit policies for cancelled or incomplete cycles.
    7. Request an estimate of non-clinic costs, such as accommodation and local transport, if the clinic provides this.

    Questions to ask a clinic before you commit

    • Which PGT tests do you offer, and which do you send to an external laboratory?
    • Is the genetic testing fee per embryo or per cycle?
    • What is included in the quoted price, and what is routinely billed separately?
    • How long does PGT-M or PGT-SR preparation take before a cycle can start?
    • What are the payment milestones, and which currencies do you accept?
    • How do you communicate results, and is there a cost for follow-up consultations?
    • Can you provide a sample quote so I can see the structure before I decide?

    Budgeting beyond the clinic invoice

    International patients should plan for costs that do not appear on a clinic quote. These include flights, accommodation for the duration of monitoring and retrieval, meals, local transport, travel insurance, and the possibility of staying longer if the timeline changes. It is also wise to keep a contingency for repeat testing or an additional cycle, since IVF outcomes are not predictable.

    If you are comparing overall treatment costs, our IVF cost in Thailand page explains the wider IVF pricing picture. For practical preparation, see patient resources. If you would like help understanding how to request quotes, you can contact us.

    Next steps

    1. Decide which PGT test is relevant to your situation with your treating clinician.
    2. Request written, itemised quotes from more than one clinic.
    3. Use the comparison checklist above to normalise the quotes.
    4. Confirm payment timing, currency and refund rules in writing.
    5. Build a travel and contingency budget alongside the clinic budget.

    Cost is only one part of the decision. Clinical suitability, laboratory arrangements and communication matter too. For a broader orientation, see our international patients page.

    Frequently asked questions

    Is PGT included in the price of an IVF cycle in Thailand?

    Not always. Some clinics bundle PGT into a package, while others bill it separately. Ask for a written quote that shows whether biopsy, genetic analysis and storage are included or charged as separate items.

    Why do PGT-M and PGT-SR quotes differ from PGT-A quotes?

    PGT-M and PGT-SR often require preparatory laboratory work that is specific to the case, such as building a probe or validating markers. That preparation can be a separate fee and may need to be completed before the IVF cycle begins. PGT-A is usually priced per embryo or in batches because it follows a more standard workflow.

    What should I check before paying a deposit?

    Confirm what the deposit covers, when the remaining balance is due, which currency is used, and what happens if the cycle is cancelled or fewer embryos are available than expected. Ask for these terms in writing.

    Can I get a refund if no embryos are suitable for testing?

    Refund and credit policies vary by clinic. Some may credit part of the fee toward a future cycle, while others may not. This is a key question to ask before you commit, and the answer should be documented in your quote or agreement.

    Are there costs outside the clinic that I should budget for?

    Yes. International patients should plan for flights, accommodation, local transport, meals, travel insurance and the possibility of a longer stay if the treatment timeline changes. It is also sensible to keep a contingency for repeat testing or an additional cycle.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT-A vs PGT-M in Thailand: Which Test Is Right for You?

    PGT-A and PGT-M are two types of preimplantation genetic testing used during IVF. PGT-A screens embryos for extra or missing chromosomes, while PGT-M looks for a specific inherited condition known to run in your family. The right test depends on your medical history, family history, and what you and your clinician aim to learn. Neither test guarantees a healthy pregnancy or baby, and not every patient needs either test. In Thailand, availability and laboratory protocols vary by clinic, so you will need to confirm details directly with your chosen provider.

    At a glance: PGT-A vs PGT-M

    • PGT-A checks the number of chromosomes in an embryo. It is often considered when age or history suggests a higher chance of chromosomal issues.
    • PGT-M looks for a specific gene change linked to a known inherited condition in the family.
    • PGT-A is broader but less specific; PGT-M is highly targeted.
    • Both require an IVF cycle and a biopsy of embryo cells.
    • Neither test can guarantee a successful pregnancy or a child without health issues.

    What is PGT-A?

    PGT-A stands for preimplantation genetic testing for aneuploidy. Aneuploidy means an embryo has an abnormal number of chromosomes—either too many or too few. Chromosome number errors are common in human embryos and become more frequent with increasing maternal age. PGT-A is used to identify embryos with a normal number of chromosomes (euploid) versus those with an abnormal number (aneuploid).

    PGT-A does not look for specific gene mutations. It is a screening test, not a diagnostic test for a particular disease. It may be offered to patients who have experienced recurrent pregnancy loss, repeated IVF failure, or who are of advanced maternal age. However, the use of PGT-A remains debated, and it is not universally recommended for all IVF patients. Some embryos with abnormal results can sometimes self-correct, and some normal embryos may fail to implant for other reasons.

    What is PGT-M?

    PGT-M stands for preimplantation genetic testing for monogenic disorders. Monogenic means caused by a single gene. PGT-M is used when there is a known risk of passing on a specific inherited condition, such as cystic fibrosis, spinal muscular atrophy, or Huntington’s disease. It requires that the exact gene mutation in the family has been identified through genetic testing of the parents or an affected family member.

    PGT-M is highly targeted. The laboratory builds a custom test to look for that specific mutation in the embryo. This means PGT-M is not a general screen; it is only useful when the mutation is known. Without prior genetic testing, PGT-M cannot be performed. PGT-M can reduce the chance of implanting an embryo affected by the condition, but it does not eliminate all risks, and it cannot guarantee a healthy child.

    How do PGT-A and PGT-M differ in purpose?

    The core difference is scope. PGT-A looks at all chromosomes broadly to detect numerical abnormalities. PGT-M looks at one specific gene to detect a known familial mutation. PGT-A is often used when there is no known inherited condition but there is a concern about chromosomal errors. PGT-M is used when a specific inherited condition is known to be present in the family.

    Another difference is the starting point. PGT-A can be done without prior genetic testing of the parents. PGT-M requires prior identification of the mutation, usually through a blood test of the parents or a relative. This makes PGT-M a more personalized and labor-intensive process.

    When might each test be considered?

    PGT-A may be discussed if you are of advanced maternal age, have a history of recurrent miscarriage, or have had multiple unsuccessful IVF cycles. Some clinics also offer it as an optional add-on for any IVF cycle, though its benefit for all patients is not firmly established.

    PGT-M is considered when you or your partner carry a known genetic mutation that could be passed on, or when you already have a child affected by a genetic condition. It is also an option for couples who are both carriers of the same recessive condition. In these cases, PGT-M can help select embryos that are not affected by the condition.

    It is important to note that neither test is a requirement for IVF. Many healthy babies are born from IVF without any genetic testing. The decision should be made with a genetic counselor and your fertility doctor, based on your individual circumstances.

    How are the laboratory processes different?

    Both PGT-A and PGT-M begin with an IVF cycle, where eggs are retrieved and fertilized to create embryos. The embryos are cultured for a few days until they reach the blastocyst stage. At that point, a few cells are removed from the outer layer (trophectoderm) in a procedure called a biopsy. The biopsied cells are sent to a genetics laboratory for analysis.

    For PGT-A, the lab uses techniques such as next-generation sequencing (NGS) to count the chromosomes. This process can be done relatively quickly and does not require a custom probe.

    For PGT-M, the lab must first develop a personalized test that can detect the specific mutation. This often involves building a probe using DNA from the parents or a reference sample. The process takes longer and requires more specialized expertise. In some cases, PGT-M may be combined with PGT-A to also check chromosome number, but this is a separate decision.

    In Thailand, not all clinics offer PGT-M, and those that do may have different laboratory protocols. You will need to ask your clinic about their experience and whether they perform the test in-house or send samples abroad.

    What are the limitations of each test?

    PGT-A can sometimes produce results that are difficult to interpret, such as mosaicism, where an embryo has a mix of normal and abnormal cells. The clinical significance of mosaicism is not fully understood, and some mosaic embryos can lead to healthy pregnancies. PGT-A also cannot detect all genetic problems; it only looks at chromosome number, not gene mutations or structural rearrangements.

    PGT-M is limited to the specific mutation it was designed to detect. It cannot rule out other genetic conditions that were not tested for. It also requires that the mutation is known and that a reliable test can be built. In some cases, the test may not be informative for all embryos. Like PGT-A, PGT-M cannot guarantee a successful pregnancy or a child free of all health issues.

    Both tests involve a biopsy, which carries a small risk of damage to the embryo, though this risk is considered low. Neither test improves the quality of the embryos themselves; they only provide information to help select which embryos to transfer.

    How to decide which test is right for you

    The choice between PGT-A and PGT-M is not a simple either/or. Some patients may be advised to have PGT-M alone, PGT-A alone, both, or neither. The decision should be based on your medical and family history, the reason for your IVF, and your goals.

    Start by discussing your family history with your doctor. If you have a known genetic condition in the family, PGT-M may be relevant. If you have a history of miscarriage or are older, PGT-A might be discussed. A genetic counselor can help you understand your risks and the implications of testing.

    Ask your clinic about their experience with each test, their laboratory partners, and how they handle results. Because PGT is a rapidly evolving field, protocols and availability can change. What is offered today may differ from what is available next year.

    Questions to ask your clinic in Thailand

    • Do you offer PGT-A and PGT-M? If not, do you refer to another clinic?
    • What laboratory do you use for genetic testing? Is it in Thailand or overseas?
    • What is your experience with PGT-M for my specific condition?
    • How do you handle mosaic results from PGT-A?
    • What are the costs involved? (Ask for a detailed breakdown.)
    • What are the success rates for my age and diagnosis? (Understand how they define success.)
    • What are the risks and limitations of each test?
    • How long does it take to get results?
    • Do you provide genetic counseling before and after testing?

    Next steps

    If you are considering PGT-A or PGT-M in Thailand, begin by gathering your personal and family medical history. Speak with a genetic counselor if you have a known inherited condition. Then consult with a fertility clinic that offers the test you are interested in. Remember that PGT is a tool, not a guarantee. It can provide useful information, but it does not replace a thorough discussion with your healthcare team about your individual chances and options.

    For more general information about PGT in Thailand, explore our PGT in Thailand guide. You can also browse our guides and FAQ for additional support.

    Frequently asked questions

    Can I have PGT-M without PGT-A?

    Yes, PGT-M can be performed alone. Some clinics may recommend combining it with PGT-A to also check chromosome number, but this is a separate decision based on your situation.

    Is PGT-A always necessary for IVF?

    No. PGT-A is not required for all IVF cycles. It may be offered in certain cases, such as advanced maternal age or recurrent miscarriage, but its benefit for all patients is still debated. Discuss with your doctor whether it is appropriate for you.

    What is the difference between PGT-A and PGT-M in terms of what they detect?

    PGT-A detects extra or missing chromosomes (aneuploidy) across all chromosomes. PGT-M detects a specific gene mutation that is known to run in your family. PGT-A is a broad screen; PGT-M is a targeted test.

    Does PGT guarantee a healthy baby?

    No. PGT can provide information about embryos, but it cannot guarantee a successful pregnancy or a child without health issues. Other factors, including maternal health and embryo quality, also play a role.

    How do I know if I need PGT-M?

    PGT-M is considered when there is a known inherited condition in your family or if you and your partner are carriers of the same genetic condition. A genetic counselor can help assess your risk and whether PGT-M is appropriate.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT Embryo Biopsy in Thailand: How the Procedure Works

    PGT embryo biopsy in Thailand is a laboratory step performed during an IVF cycle, usually on day 5 or day 6 after egg retrieval, when an embryo has reached the blastocyst stage. A small sample of cells is taken from the outer layer (trophectoderm) and sent for genetic testing, while the embryo is frozen. The biopsy itself is brief, but the timing depends on embryo development, and the exact protocol varies by clinic. Your treating clinic confirms whether biopsy is appropriate for you and how it fits your timeline.

    At a glance

    • Biopsy is a lab procedure, not a separate surgery for the patient.
    • It is typically done on day 5 or day 6 after egg retrieval, when the embryo reaches the blastocyst stage.
    • The sample is taken from the trophectoderm, the cells that would form the placenta.
    • After biopsy, the embryo is usually frozen while testing is completed.
    • Timelines, lab methods, and whether biopsy is offered at all must be confirmed with your treating clinic.

    What PGT embryo biopsy is and where it fits in IVF

    Preimplantation genetic testing (PGT) is a group of lab tests that look at the chromosomes or specific genes in an embryo. To run those tests, the lab needs a few cells from the embryo. The process of removing those cells is called embryo biopsy.

    Biopsy is not a treatment on its own. It is one step inside a larger IVF cycle that includes ovarian stimulation, egg retrieval, fertilisation, embryo culture, biopsy, testing, and later a frozen embryo transfer if a suitable embryo is available. For an overview of how these steps connect, see IVF in Thailand and the general treatment process.

    PGT is not routine for every IVF cycle. Whether it is relevant depends on your medical history, the reason for testing, and your clinic’s assessment. That decision is made by your treating clinician, not by a website or a general guide.

    Why biopsy timing matters

    Embryo biopsy is timed to a specific stage of development. In most modern PGT cycles, the lab waits until the embryo becomes a blastocyst, usually around day 5 or day 6 after fertilisation. At this stage, the embryo has two distinct parts: an inner cell mass that would become the fetus, and an outer trophectoderm layer that would become the placenta.

    Taking cells from the trophectoderm allows the lab to test the embryo while leaving the inner cell mass undisturbed. This is one reason blastocyst-stage biopsy has become common in many laboratories. However, not every embryo reaches blastocyst stage, and not every embryo that reaches it will be suitable for biopsy. The embryology team makes that call on the day.

    Some clinics may discuss other biopsy timings, such as polar body or cleavage-stage biopsy, for specific situations. These are less common in many current PGT programmes, but practice varies. If you have questions about which approach a clinic uses, ask directly.

    Biopsy day: what happens in the laboratory

    Biopsy day is a laboratory milestone, not a procedure you feel. You will not normally be in the room, and there is usually no additional anaesthesia or recovery for you on that day.

    The sequence typically looks like this:

    1. Embryo assessment. The embryology team reviews each embryo’s development, checking whether it has reached the blastocyst stage and whether it meets the clinic’s criteria for biopsy.
    2. Preparation. The embryo is placed in a specialised dish under a microscope. The lab uses micromanipulation tools and a laser or mechanical method to make a small opening in the outer layer.
    3. Cell sampling. A small number of trophectoderm cells are gently aspirated through the opening. The exact number of cells can vary by clinic and embryo.
    4. Embryo handling after biopsy. The biopsied embryo is usually vitrified (frozen) while the sample is prepared for testing. The sample is labelled and processed according to the lab’s protocol.
    5. Testing. The sample is sent for genetic analysis, either within the same laboratory or to a partner genetics laboratory. The testing method depends on the type of PGT requested.

    The biopsy itself is a delicate micromanipulation procedure. It requires an experienced embryologist and a laboratory set up for embryo biopsy. If you are comparing clinics, you can ask how many biopsy procedures the lab performs and how it handles sample tracking and chain of custody.

    Lab workflow after biopsy

    After biopsy, the workflow moves from the IVF laboratory to the genetics laboratory. The sample is processed to extract DNA, and the requested test is run. The time from biopsy to a result can vary depending on the test, the laboratory’s schedule, and whether the sample needs to be shipped.

    Because the embryo is usually frozen after biopsy, the transfer is planned for a later cycle. This gives the clinic time to receive the test result and discuss it with you. The exact interval between biopsy and transfer is clinic-specific and should be confirmed with your treating team.

    For international patients, it helps to understand that the biopsy and testing phase is mostly a waiting period. You may be able to return home after egg retrieval and biopsy, then plan a frozen embryo transfer for a later trip. Travel timing depends on your clinic’s schedule and your own circumstances. See international patients for general planning considerations.

    What biopsy does not tell you

    PGT biopsy provides a sample for testing. It does not guarantee a pregnancy, a live birth, or a healthy child. It also does not replace other assessments your clinician may recommend. Test results can be complex, and some results are uncertain or need genetic counselling to interpret.

    This guide does not cover how to interpret PGT results or which patients should consider PGT. Those are clinical decisions. If you want to understand the role of PGT in treatment planning, start with PGT in Thailand and discuss your specific situation with a qualified clinician.

    Questions to ask your clinic about biopsy

    Because protocols differ, the most reliable information comes from the clinic that will handle your embryos. Consider asking:

    • On which day after egg retrieval does your laboratory usually perform biopsy?
    • Do you use trophectoderm biopsy, and are there situations where you use another method?
    • Who performs the biopsy, and what is the embryologist’s experience with this procedure?
    • How are biopsied embryos frozen and stored?
    • Where is the genetic testing performed, and how long does a result usually take?
    • How will I receive the result, and what support is available to understand it?
    • What happens if an embryo is not suitable for biopsy on the day?
    • What costs are associated with biopsy and testing, and how are they billed?

    You can also ask for a written summary of the laboratory workflow so you know what to expect at each stage.

    Planning checklist for international patients

    • Confirm with your clinic whether PGT is appropriate for your situation before planning travel.
    • Ask how many days you need to be in Thailand for monitoring, egg retrieval, and any post-retrieval checks.
    • Clarify whether biopsy happens during the same trip or whether you can travel home before the frozen transfer.
    • Ask how results are communicated and whether a follow-up consultation is included.
    • Check what documents, consent forms, and payments are required, and whether any need translation.
    • Confirm storage arrangements and any ongoing fees for frozen embryos.
    • Keep a copy of your treatment plan and lab reports for your own records.

    Visa rules, document requirements, and legal considerations can change. Confirm these with the relevant authority and your treating clinic rather than relying on general information.

    How biopsy fits into the wider IVF timeline

    For a typical PGT cycle, the broad sequence is:

    1. Ovarian stimulation and monitoring.
    2. Egg retrieval and fertilisation.
    3. Embryo culture to blastocyst stage.
    4. Embryo biopsy on day 5 or day 6, if the embryo is suitable.
    5. Embryo freezing and genetic testing.
    6. Results review and planning for a frozen embryo transfer.
    7. Frozen embryo transfer in a later cycle.

    This is a general outline. Your own timeline may differ based on your response to stimulation, embryo development, and your clinic’s protocols. Your treating team is the best source for your individual schedule.

    Next steps

    If you are researching PGT embryo biopsy in Thailand, start by clarifying your clinical questions with a qualified provider. Use the general guides on PGT in Thailand, IVF in Thailand, and treatment process to build your understanding, then bring your specific questions to a consultation. For travel and planning, see international patients.

    Frequently asked questions

    Is embryo biopsy painful for the patient?

    No. Embryo biopsy is performed in the laboratory on the embryo, not on your body. You do not need anaesthesia for the biopsy itself, and there is no recovery period for you on biopsy day. Any discomfort you experience is related to the earlier egg retrieval, not the biopsy.

    How long does the biopsy procedure take?

    The biopsy of a single embryo is a brief micromanipulation procedure, typically measured in minutes. The overall laboratory workflow on biopsy day includes assessment, handling, and labelling of each embryo, so the full process takes longer than the biopsy of one embryo alone. Your clinic can explain its typical laboratory schedule.

    Can I travel home before the embryo transfer?

    In many PGT cycles, embryos are frozen after biopsy while testing is completed, so transfer is planned for a later cycle. Whether you can travel home in between depends on your clinic's advice and your own situation. Ask your treating team how they usually plan travel for international patients.

    Does biopsy damage the embryo?

    Biopsy removes a small sample of cells from the trophectoderm, the outer layer that would form the placenta. Laboratories use techniques designed to minimise disturbance to the embryo. However, no procedure is without risk, and not every embryo remains suitable for transfer after biopsy. Your clinic can explain the specific risks and its own experience.

    Will PGT biopsy guarantee a healthy baby?

    No. PGT biopsy provides a sample for genetic testing, but it cannot guarantee a pregnancy, a live birth, or a healthy child. Test results can be complex, and some findings are uncertain. Your clinic and a genetic counsellor can help you understand what a result does and does not mean for your situation.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT-M for Hereditary Conditions in Thailand: A Patient Guide

    PGT-M (preimplantation genetic testing for monogenic disease) is a laboratory step used during IVF to test embryos for a specific inherited condition that is already known to run in a family. It is not a general health screen and it does not test for every possible disorder. It is designed around one condition, or a small number of conditions, identified in advance through genetic counselling and confirmatory testing. In Thailand, PGT-M is offered by some fertility clinics, but availability, laboratory arrangements and eligibility criteria vary. This guide explains the purpose of PGT-M, the kinds of conditions it may be used for, and the practical questions international patients should ask before planning treatment.

    At a glance

    • What it is: A targeted genetic test on embryos created through IVF, looking for a known inherited condition.
    • What it is not: A guarantee of a healthy child, a general screening test, or a replacement for prenatal testing.
    • Who it may suit: People with a confirmed family history or carrier status for a specific monogenic condition.
    • Key first step: Genetic counselling and a clear genetic diagnosis before IVF is planned.
    • In Thailand: Confirm that the clinic can build or access a test specific to your condition and that the laboratory is accredited for that work.

    What PGT-M actually tests for

    PGT-M is used when a specific gene change (a pathogenic variant) has been identified in a family. The test looks at embryos created through IVF to see whether they have inherited that variant. It is sometimes called monogenic disease testing because it targets conditions caused by a change in a single gene.

    Examples of conditions that may be considered for PGT-M include cystic fibrosis, spinal muscular atrophy, thalassaemia, Huntington’s disease, fragile X syndrome, and some inherited cancer syndromes. This is not a complete list, and whether PGT-M is appropriate depends on the specific condition, the inheritance pattern, and the genetic information available from the family.

    PGT-M is different from PGT-A, which counts chromosomes and is used more broadly. PGT-M is also different from PGT-SR, which looks at structural chromosome rearrangements. If you are researching PGT generally, it helps to keep these categories separate, because they answer different questions.

    Which conditions may qualify for PGT-M

    PGT-M is generally considered when all of the following apply:

    • A specific inherited condition has been diagnosed in the family or confirmed through carrier testing.
    • The gene or genes involved are known, and the laboratory can design a reliable test.
    • The condition is serious enough that a family wishes to avoid passing it on, and other options have been discussed.
    • Genetic counselling has taken place, so the patient understands the inheritance pattern and the limits of testing.

    Conditions with a clear single-gene cause are the most straightforward to test for. Conditions caused by many genes plus environment, or by unknown genes, are generally not suitable for PGT-M. Some conditions also require a custom test to be built, which takes time and may not be available at every clinic.

    Inheritance patterns matter

    How a condition is inherited affects who may be at risk and what testing can show. Autosomal recessive conditions, such as cystic fibrosis or thalassaemia, require both partners to be carriers. Autosomal dominant conditions, such as Huntington’s disease, can be passed on by one affected parent. X-linked conditions, such as some forms of muscular dystrophy, have a different pattern. A genetic counsellor or clinical geneticist can explain which pattern applies to your family.

    What the PGT-M process involves

    The exact steps vary by clinic and by condition, but the general sequence is usually similar.

    1. Genetic counselling and confirmation. A clinical geneticist or genetic counsellor reviews the family history and confirms the exact gene variant. This often requires a blood or saliva sample from the affected person or carrier.
    2. Test development. The laboratory designs a test that can reliably detect that variant in a single cell or a few cells taken from an embryo. This step can take weeks or longer and may not be possible for every condition.
    3. IVF cycle. Eggs are collected and fertilised in the laboratory to create embryos.
    4. Embryo biopsy. A small number of cells are removed from each embryo, usually at the blastocyst stage.
    5. Genetic analysis. The biopsy samples are tested for the specific variant.
    6. Embryo transfer. An embryo that does not carry the variant may be selected for transfer, if one is available and suitable.
    7. Prenatal testing. Even after PGT-M, many clinics recommend confirmatory testing during pregnancy, such as chorionic villus sampling or amniocentesis, because PGT-M is a screening test for embryo selection and not a diagnostic test of the pregnancy.

    What to confirm with a clinic in Thailand

    Because PGT-M is highly specific, the most important question is whether the clinic and its laboratory can actually test for your condition. General IVF experience is not the same as experience with a particular monogenic disease.

    Questions worth asking:

    • Have you handled PGT-M for this specific condition before?
    • Do you build custom tests in-house, or do you send samples to an external laboratory?
    • Which laboratory performs the analysis, and what accreditation does it hold?
    • What genetic information do you need from my family before you can confirm the test is possible?
    • How long does test development take, and what happens if the test cannot be built?
    • What are the limitations of the test in my case, including the chance of an inconclusive result?
    • Do you require genetic counselling before treatment, and can it be done remotely?
    • What is your policy on confirmatory prenatal testing?
    • What documents do international patients need to provide, and how are they verified?
    • What are the estimated costs, and what is included or excluded?

    Costs, document requirements and legal rules can change and vary between clinics. Treat any figure or requirement you see online as something to confirm directly with the clinic and, where relevant, with the appropriate authority.

    Limitations and alternatives

    PGT-M is not a guarantee. It reduces the chance of transferring an embryo with a specific known variant, but it cannot eliminate all risk. Some embryos may be mosaic, meaning the biopsy result may not reflect the whole embryo. Some tests may give an inconclusive result. And PGT-M does not screen for other genetic conditions, chromosomal issues, or health problems that appear later in life.

    Alternatives to consider, depending on your situation, include:

    • Using donor eggs or donor sperm.
    • Prenatal diagnosis during pregnancy, with or without IVF.
    • Preimplantation genetic testing for aneuploidy (PGT-A) or for structural rearrangements (PGT-SR), if those are more relevant to your case.
    • Choosing not to have genetic testing and accepting the natural chance of inheritance.
    • Adoption or fostering.

    These are personal decisions, and a genetic counsellor can help you weigh them without pressure.

    Planning as an international patient

    If you are travelling to Thailand for PGT-M, plan for more than one trip in many cases. The first visit may be for consultation and blood samples; the IVF cycle and embryo testing happen later. Ask the clinic how results are communicated, what happens if no unaffected embryo is available, and how follow-up is arranged once you return home.

    It also helps to have a clear summary of your genetic diagnosis in English, including the gene name, the specific variant, and the inheritance pattern. This document is often requested before a clinic can confirm whether PGT-M is possible.

    Next steps

    • Speak with a genetic counsellor or clinical geneticist about your family history.
    • Obtain written confirmation of the exact gene variant.
    • Shortlist clinics that have experience with your specific condition.
    • Ask each clinic the questions above and compare their answers.
    • Confirm costs, timelines, and document requirements directly.
    • Read more about PGT in Thailand and browse our guides for related topics.

    Frequently asked questions

    Is PGT-M the same as PGT-A?

    No. PGT-M looks for a specific inherited condition caused by a known gene variant. PGT-A counts chromosomes and is used to check for an abnormal number of chromosomes. They answer different questions and may be used together in some cases.

    Can any clinic in Thailand offer PGT-M?

    Not necessarily. PGT-M requires a laboratory that can build or access a test for your specific condition. Availability varies, so you should confirm directly with the clinic whether they can test for your condition and which laboratory performs the analysis.

    Does PGT-M guarantee a healthy baby?

    No. PGT-M reduces the chance of transferring an embryo with a specific known variant, but it cannot eliminate all genetic or health risks. It does not test for every condition, and confirmatory prenatal testing is often recommended.

    What information do I need before asking a clinic about PGT-M?

    You will usually need a clear genetic diagnosis, including the gene name, the specific variant, and the inheritance pattern. A genetic counsellor or clinical geneticist can provide this, often after reviewing family history and test results.

    Are there alternatives to PGT-M?

    Depending on your situation, alternatives may include using donor eggs or sperm, prenatal diagnosis during pregnancy, or choosing not to have genetic testing. A genetic counsellor can explain the options and their limitations.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT-A Testing in Thailand for International Patients: Who It May Help and What It Screens

    PGT-A (preimplantation genetic testing for aneuploidy) is a laboratory test that can be performed on embryos created during IVF. It looks for extra or missing chromosomes — a condition called aneuploidy — before an embryo is transferred. It is not a treatment, not a guarantee of pregnancy, and not automatically necessary for everyone. Whether it is useful depends on your age, your IVF history, how many embryos you have, and what you and your clinician are trying to learn. This guide explains what PGT-A screens, how it differs from other PGT tests, who may reasonably consider it, and what to confirm directly with a clinic in Thailand.

    At a glance

    • What it is: A lab test on a small sample of embryo cells, usually at the blastocyst stage.
    • What it screens: Extra or missing whole chromosomes (aneuploidy), not single-gene disorders and not all structural chromosome problems.
    • What it does not do: It cannot guarantee a healthy pregnancy, a live birth, or a healthy child. It does not diagnose a disease in you.
    • Who may consider it: Often discussed with older patients, those with repeated implantation failure or recurrent pregnancy loss, or those with many embryos who want more information before transfer.
    • Key trade-off: More information about chromosome number, but also possible embryo loss from testing, biopsy risk, cost, and the chance of a result that is hard to interpret.
    • In Thailand: Availability, lab arrangements, and which patients are offered PGT-A vary by clinic. Confirm details directly.

    What PGT-A actually screens

    Human cells normally contain 46 chromosomes arranged in 23 pairs. Aneuploidy means there is an extra or missing chromosome. Common examples include trisomy 21 (an extra copy of chromosome 21), trisomy 18, and trisomy 13, as well as missing or extra sex chromosomes. Aneuploidy is a common cause of miscarriage and can also be present in embryos that fail to implant.

    PGT-A estimates the number of chromosomes in the cells sampled from an embryo. It does not read the full DNA sequence, so it does not detect most single-gene conditions such as cystic fibrosis or spinal muscular atrophy. It also has limits for certain structural rearrangements, small deletions or duplications, and mosaic results (where different cells in the same embryo have different chromosome numbers).

    Because only a few cells are removed, PGT-A is a screening test, not a definitive diagnosis. A “normal” result reduces but does not eliminate the chance of aneuploidy, and it cannot predict whether an embryo will implant, grow normally, or result in a healthy baby.

    PGT-A, PGT-M, and PGT-SR: how they differ

    PGT is an umbrella term. The three main types answer different questions:

    Test What it looks for Typical situation
    PGT-A Extra or missing whole chromosomes (aneuploidy) General embryo screening during IVF; often discussed with older patients or those with repeated IVF failure or miscarriage
    PGT-M A specific single-gene condition known to run in the family When one or both parents carry a gene variant for a condition such as thalassemia or cystic fibrosis
    PGT-SR Structural chromosome rearrangements, such as translocations When a parent has a known balanced translocation or similar rearrangement

    Some clinics combine PGT-A with PGT-M or PGT-SR when both are relevant. The choice of test should follow a clinical discussion, not a default package.

    Who may benefit from PGT-A — and who may not

    PGT-A is not recommended for every IVF patient. Professional guidance generally supports discussing it in specific situations rather than offering it universally. It may be more relevant if you:

    • Are older, since the proportion of aneuploid embryos tends to rise with age.
    • Have a history of recurrent pregnancy loss, where aneuploidy is a common contributing factor.
    • Have had repeated IVF cycles without implantation, after other causes have been reviewed.
    • Have several embryos and want more information to help prioritize which to transfer.
    • Have a previous pregnancy or pregnancy loss known to have been aneuploid.

    It may be less clearly beneficial if you:

    • Have very few embryos, because testing can reduce the number available for transfer.
    • Are younger with a good prognosis and no history suggesting higher aneuploidy risk.
    • Prefer to avoid the possibility of losing embryos to the testing process.
    • Have a mosaic or uncertain result that could complicate decision-making.

    These are general considerations, not eligibility rules. Your own situation should be assessed by your treating clinician.

    How PGT-A fits into an IVF cycle

    1. Ovarian stimulation and egg retrieval — standard IVF steps.
    2. Fertilization and embryo culture — embryos grow in the lab for several days, often to the blastocyst stage.
    3. Embryo biopsy — a small number of cells are removed from the trophectoderm (the outer layer that becomes the placenta). This is a lab procedure, not a treatment for the embryo.
    4. Sample analysis — the cells are tested for chromosome number. Some clinics send samples to a partner laboratory; others use an in-house lab.
    5. Embryo freezing and storage — because testing takes time, embryos are usually frozen and transferred in a later cycle.
    6. Results discussion — you and your clinician review which embryos are available and how to proceed.
    7. Transfer — one or more embryos may be transferred, depending on your plan and clinic guidance.

    Timelines vary. Ask your clinic how long testing takes, how embryos are stored, and what happens if results are inconclusive.

    Limitations and uncertainties to understand

    • It is a screening test. A low-risk result does not guarantee a chromosomally normal pregnancy or a healthy child.
    • Mosaic results. Some embryos show a mix of normal and abnormal cells. These results can be difficult to interpret, and policies on transferring mosaic embryos vary.
    • Embryo loss. Biopsy and freezing can reduce the number of embryos available for transfer. Not every embryo survives the process.
    • No improvement guarantee. Studies have not consistently shown that PGT-A improves live birth rates for all patients. It may reduce miscarriage risk in some groups, but it does not treat infertility itself.
    • Technical limits. PGT-A does not detect all genetic conditions, and it cannot assess non-chromosomal causes of implantation failure.
    • Cost and access. PGT-A adds laboratory and biopsy costs. These vary by clinic and are not covered here.

    Alternatives and add-ons to discuss

    Depending on your situation, your clinician may discuss:

    • IVF without PGT-A — transferring untested embryos, with standard ultrasound and, where appropriate, other screening during pregnancy.
    • PGT-M or PGT-SR — if a specific inherited condition or structural rearrangement is relevant.
    • Embryo grading — a visual assessment that does not test chromosomes but can inform transfer decisions.
    • Donor eggs or sperm — in some cases, this changes the aneuploidy risk profile.
    • Prenatal testing — such as chorionic villus sampling or amniocentesis, which can confirm chromosome status during pregnancy.

    No single option is right for everyone. The goal is to match the test to your question, not to add tests by default.

    How PGT-A is discussed in Thailand

    Thailand has a well-established IVF sector serving international patients, and PGT-A is offered at many clinics. However, practices differ. Some clinics offer PGT-A routinely to certain age groups; others discuss it case by case. Laboratory arrangements — whether testing is done in-house or through a partner lab — also vary, and this can affect turnaround time and how results are reported.

    Because regulations, clinic policies, and laboratory practices can change, treat any specific claim about availability, eligibility, or process as something to verify directly with the clinic you are considering. For general guidance on preparing for treatment in Thailand, see our international patients page and PGT in Thailand overview.

    Questions to ask a clinic before deciding

    • Do you recommend PGT-A for my situation, and why or why not?
    • What exactly does your PGT-A test screen for, and what does it not detect?
    • Is testing done in your laboratory or sent elsewhere? Who analyzes the samples?
    • How do you handle mosaic or inconclusive results?
    • What proportion of embryos typically remain available for transfer after biopsy and freezing at your clinic?
    • What are the additional costs, and what do they include?
    • How long does testing take, and how are embryos stored in the meantime?
    • What are my alternatives if I choose not to test?
    • Who will explain the results to me, and in what language?
    • What follow-up or prenatal testing do you recommend after transfer?

    Next-step checklist

    1. Clarify your own reasons for considering PGT-A — what question are you trying to answer?
    2. Ask your clinician whether PGT-A is likely to change your treatment plan.
    3. Request written information about the test, its limits, and the clinic’s laboratory arrangements.
    4. Ask about costs, timelines, and what happens to embryos that are not transferred.
    5. Consider a second opinion if the recommendation feels routine rather than personalized.
    6. Review our guides and FAQ for more context on IVF and PGT decisions.

    PGT-A can provide useful information in some situations, but it is one part of a larger decision. The most reliable next step is a direct conversation with a qualified clinician who can review your history and explain what testing can and cannot do for you.

    Frequently asked questions

    Is PGT-A the same as PGT-M or PGT-SR?

    No. PGT-A screens for extra or missing whole chromosomes (aneuploidy). PGT-M looks for a specific single-gene condition known to run in a family. PGT-SR looks for structural chromosome rearrangements such as translocations. They answer different questions and may be used together in some cases.

    Does PGT-A guarantee a healthy baby?

    No. PGT-A is a screening test. A low-risk result reduces but does not eliminate the chance of aneuploidy, and it cannot predict implantation, pregnancy, or child health. It does not detect all genetic conditions.

    Who is usually offered PGT-A?

    It is often discussed with patients who are older, have a history of recurrent pregnancy loss or repeated IVF failure, or have several embryos and want more information before transfer. It is not universally recommended, and eligibility is a clinical decision.

    Can PGT-A results be uncertain?

    Yes. Some embryos show mosaic results, where different cells have different chromosome numbers. These can be difficult to interpret, and clinic policies on transferring mosaic embryos vary. Ask your clinic how they handle uncertain results.

    What should I ask a clinic in Thailand about PGT-A?

    Ask whether they recommend it for your situation, what the test screens for, whether testing is done in-house or sent to a partner lab, how mosaic results are handled, what the additional costs are, how long results take, and what alternatives exist if you choose not to test.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • IVF in Thailand FAQ: Common Questions from International Patients

    IVF in Thailand is a common option for international patients who want to combine medical treatment with travel. The short answer: Thailand has many fertility clinics that serve patients from abroad, but the details of your treatment, costs, timeline, and legal requirements depend on your individual situation and the clinic you choose. This FAQ covers the questions patients ask most often, explains where uncertainty is normal, and suggests what to confirm directly with a clinic before you commit.

    At a glance

    • What it is: IVF (in vitro fertilization) is a fertility treatment where eggs and sperm are combined outside the body, and an embryo may be transferred to the uterus.
    • Who it may suit: People with various fertility diagnoses, but eligibility is a medical decision made by your treating doctor.
    • Why Thailand: Many clinics offer international patient services, and treatment may be more affordable than in some other countries. Exact costs vary.
    • What to confirm: Clinic credentials, doctor experience, laboratory arrangements, pricing structure, and any legal or documentation requirements.
    • How to start: Gather your medical records, contact a few clinics, ask the same questions, and compare written responses.

    What is IVF, and how does it work in simple terms?

    IVF stands for in vitro fertilization. In a typical cycle, a doctor may prescribe fertility medications to stimulate the ovaries to produce multiple eggs. Those eggs are then collected in a minor procedure. In the laboratory, eggs and sperm are combined to attempt fertilization. If embryos develop, one or more may be transferred to the uterus, and any remaining embryos may be frozen for future use.

    Your exact protocol, medication, and monitoring schedule will be determined by your treating doctor based on your medical history, age, ovarian reserve, and other factors. No two patients follow exactly the same path, and outcomes cannot be guaranteed.

    Why do international patients consider Thailand for IVF?

    Thailand has a well-established medical tourism sector, and many fertility clinics have experience serving patients from other countries. Common reasons patients mention include:

    • Availability of IVF and related laboratory techniques.
    • Potentially lower treatment costs compared with some other destinations, though prices vary widely by clinic and protocol.
    • Travel infrastructure and options for combining treatment with a stay abroad.
    • Clinics that offer English-speaking coordinators or translation support.

    These are general observations, not endorsements. You should verify any specific claim directly with the clinic you are considering.

    What are the basic steps of IVF treatment abroad?

    While every clinic has its own process, international patients often move through a sequence like this:

    1. Initial contact and records review: You share your medical history, test results, and previous treatment records. The clinic may ask for additional tests.
    2. Consultation and treatment plan: A doctor discusses whether IVF is appropriate for you, what protocol might be used, and what the timeline could look like.
    3. Pre-treatment preparation: Some tests or medications may be started in your home country, depending on the clinic’s instructions.
    4. Travel and monitoring: You may need to be in Thailand for part of the cycle. The length of stay depends on your protocol.
    5. Egg retrieval and fertilization: These steps happen at the clinic and laboratory.
    6. Embryo transfer: If embryos are available, a transfer may be scheduled. Some patients use frozen embryo transfer in a later cycle.
    7. Follow-up and pregnancy testing: The clinic will advise on when and how to test, and what follow-up is needed.

    Timelines vary. Ask the clinic for a written estimate of how long each stage typically takes for a patient in your situation.

    How much does IVF in Thailand cost?

    Costs vary significantly depending on the clinic, the treatment protocol, medications, laboratory techniques used, and whether you need additional services such as genetic testing of embryos or frozen embryo transfer. There is no single price for IVF in Thailand.

    When you request a quote, ask for a breakdown that includes:

    • Consultation and monitoring fees.
    • Medication costs (these can be a large portion of the total).
    • Laboratory and procedure fees.
    • Embryo freezing and storage fees, if applicable.
    • Any additional techniques your doctor recommends.
    • What is not included, such as travel, accommodation, or tests done in your home country.

    Be cautious of quotes that seem unusually low or that do not itemize. Ask whether the price is guaranteed or can change during treatment.

    What should I ask a clinic before choosing it?

    Asking the same questions to several clinics can help you compare. Consider asking:

    • Who will be my treating doctor, and what are their credentials and experience with patients like me?
    • What laboratory techniques do you use, and how do you monitor embryo development?
    • What are your success rates, and how do you define success? (Be aware that success rates can be presented in different ways and may not be directly comparable between clinics.)
    • What is the full cost estimate, including medications and any extras?
    • How long will I need to stay in Thailand, and can any part of the treatment be done in my home country?
    • What support do you offer for international patients, such as language interpretation or help with travel logistics?
    • What are your policies on embryo storage, donation, and disposal?
    • What legal or documentation requirements apply to me as a foreign patient?

    Get answers in writing where possible. If a clinic is vague or evasive, that is useful information.

    What legal or documentation issues should I be aware of?

    Laws and clinic policies regarding fertility treatment for foreign patients can change. Requirements may relate to marriage status, age, legal gender, or the type of treatment requested. Some clinics may ask for passports, marriage certificates, or other documents, and may require them to be translated or certified.

    Because these rules are specific and can change, you should confirm the current requirements directly with the clinic and, if needed, with a legal professional familiar with Thai law. Do not rely on general information online, including this article, for legal advice.

    How do I plan travel and accommodation?

    Travel planning depends on how long you need to stay. Ask your clinic for a realistic estimate of the number of days you will need to be in Thailand for monitoring, procedures, and recovery. Some patients need only a short stay; others may need several weeks.

    Consider:

    • Booking flexible flights and accommodation in case your schedule changes.
    • Staying near the clinic to reduce travel time for frequent monitoring appointments.
    • Travel insurance that covers medical care and trip interruption, if available.
    • Visa or entry requirements for your nationality, which you should verify with official government sources.

    Your clinic’s international patient coordinator may be able to suggest local services, but you should verify any recommendations independently.

    What emotional and practical support might I need?

    IVF can be emotionally and physically demanding, and traveling abroad adds logistical stress. It can help to:

    • Ask about counseling or support groups at the clinic or online.
    • Bring a partner, friend, or family member if possible.
    • Plan for rest and avoid scheduling too many activities during treatment.
    • Keep a record of your medications, appointments, and questions.

    Remember that you are not alone, and it is okay to ask for help.

    What if I have more questions?

    This FAQ covers common topics, but your situation is unique. For more detailed guides on specific aspects of IVF and fertility treatment, explore our guides. If you have a question that is not answered here, you can contact us or check our main FAQ page for additional information.

    Next steps checklist

    • Gather your medical records and recent test results.
    • Make a list of questions and ask several clinics.
    • Request written cost estimates and treatment timelines.
    • Verify legal and documentation requirements with the clinic and official sources.
    • Plan travel with flexibility and consider insurance.
    • Arrange emotional support before, during, and after treatment.

    Frequently asked questions

    Is IVF in Thailand safe?

    IVF is a medical procedure with risks, as with any treatment. Safety depends on the clinic, the doctor's experience, laboratory standards, and your individual health. You should ask clinics about their credentials, protocols, and how they handle complications. No clinic can guarantee a risk-free outcome.

    How long do I need to stay in Thailand for IVF?

    The length of stay varies depending on your treatment protocol. Some patients need to be in Thailand for a few days for monitoring and procedures, while others may need several weeks. Your clinic can give you a more specific estimate after reviewing your case.

    Can I use my own eggs and sperm?

    In many cases, yes, but this depends on your medical situation and the clinic's assessment. Some patients may need donor eggs, donor sperm, or both. Your doctor will discuss what is appropriate for you.

    What is the success rate of IVF in Thailand?

    Success rates vary widely by clinic, patient age, diagnosis, and treatment protocol. Clinics may report success rates differently, so they are not always directly comparable. You should ask a clinic how they define and measure success, and what their rates are for patients with a similar profile to yours. No clinic can guarantee a successful pregnancy.

    Do I need a visa to travel to Thailand for IVF?

    Visa requirements depend on your nationality and the length of your stay. You should check with the Thai embassy or consulate in your country, or an official government website, for the most current information. Your clinic may provide a letter to support your visa application, but they cannot guarantee visa approval.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • IVF for LGBTQ+ Patients in Thailand: A Practical Guide to Access, Legality, and Planning

    Thailand has become a destination for LGBTQ+ international patients seeking fertility care, but access and legality depend on your specific situation. Thai law and clinic policies can affect who can receive treatment, what documents are required, and how parentage is recognized. This guide helps you ask the right questions, plan practically, and avoid assumptions. It does not provide legal advice or medical recommendations. Always confirm current rules with the treating clinic and a qualified Thai legal professional.

    At a glance

    • Legal access for LGBTQ+ patients in Thailand is not uniform; it depends on your relationship status, nationality, and the type of treatment.
    • Clinics may have their own eligibility policies that are stricter than the law.
    • Documentation requirements vary; ask for a written checklist before you travel.
    • Remote consultations can clarify whether a clinic can serve you before you commit to travel.
    • Privacy and communication preferences should be discussed early.
    • Plan for flexibility in travel dates and a clear follow-up plan in your home country.

    Legal considerations for LGBTQ+ patients

    Thai law around fertility treatment and parentage is complex and has changed in recent years. It is not possible to give a single answer that applies to all LGBTQ+ patients. Key factors that may affect access include:

    • Your marital or relationship status and how it is recognized in Thailand.
    • Your nationality and the nationality of any partner.
    • Whether you are seeking treatment as a single person, a same-sex couple, or a different family structure.
    • The type of treatment (for example, IVF with your own gametes versus treatment involving donor gametes or a gestational carrier).

    Because these rules can change and may be interpreted differently by different clinics, you should:

    • Ask the clinic directly whether they currently accept patients in your situation.
    • Request a written summary of the legal and documentary requirements they apply.
    • Consult an independent Thai lawyer with experience in family and fertility law to understand parentage and exit requirements.
    • Check the rules in your home country for recognizing a child born through treatment abroad.

    This guide cannot tell you whether you are eligible or what the law requires in your case. Those are questions for the clinic and a legal professional.

    Questions to ask a clinic before you commit

    Use these questions to screen clinics and clarify what is possible. Ask for answers in writing so you can review them carefully.

    • Do you currently provide IVF to LGBTQ+ patients in my specific situation (single, same-sex couple, etc.)?
    • What documents do you require from me and my partner, if applicable?
    • Do you require any legal documents, such as a marriage certificate, affidavit, or consent form?
    • How do you handle donor gametes or gestational carriers, if that is part of my treatment?
    • What are your policies on privacy and communication with me?
    • Can you provide a written treatment plan and cost estimate before I travel?
    • What is your process for remote consultations and follow-up?
    • What happens if I need to change my travel dates?
    • Who will be my main point of contact, and how quickly do they respond?
    • Can you share your approach to coordinating with my doctor at home?

    Documentation and preparation

    Document requirements vary by clinic and by your situation. Common categories to prepare may include:

    • Passport and visa-related documents for travel.
    • Identification for both partners, if applicable.
    • Marriage or relationship certificates, if relevant and available.
    • Medical records, including any previous fertility tests or treatments.
    • Legal documents requested by the clinic, such as consent forms or affidavits.
    • Proof of address or contact details for follow-up.

    Do not assume that a document accepted by one clinic will be accepted by another. Ask for a checklist and confirm whether translations or notarizations are needed. Keep both digital and paper copies.

    Remote consultations and communication

    Remote consultations can help you decide whether a clinic is a good fit before you travel. They are also useful for discussing sensitive topics. Consider the following:

    • Ask whether interpreters are available and whether they are medically trained.
    • Confirm the language of written materials and consent forms.
    • Request a summary of what was discussed after each consultation.
    • Clarify how urgent questions are handled outside of scheduled appointments.
    • Discuss how your privacy will be protected, including who can access your records.
    • Ask whether consultations can be recorded for your own reference, if that helps you.

    Good communication is a two-way process. If you feel rushed or unclear, ask for clarification before making decisions.

    Privacy and respectful care

    Privacy is a common concern for LGBTQ+ patients. You may want to ask:

    • How does the clinic protect my personal and medical information?
    • Who in the clinic will know about my treatment?
    • How will staff address me and my partner?
    • What is the clinic’s policy on sharing information with anyone else?
    • Can I request a private waiting area or specific appointment times?

    You have the right to ask these questions and to choose a clinic that respects your identity and circumstances.

    Travel, accommodation, and flexibility

    Treatment timelines can be unpredictable. Build flexibility into your travel plans.

    • Ask the clinic for an estimated length of stay, but understand that it may change.
    • Choose accommodation that allows changes or extensions.
    • Consider travel insurance that covers medical and trip interruption, and check what it covers.
    • Keep some buffer days before and after your expected treatment window.
    • Ask the clinic for a list of nearby accommodation options if you need them.
    • Plan for how you will get to and from appointments.

    If you are traveling with a partner, confirm that the clinic can accommodate both of you in consultations and that your partner’s role is recognized in their processes.

    Follow-up care after you return home

    Continuity of care matters. Before you leave Thailand, ask:

    • What follow-up tests or appointments will I need, and when?
    • Can you provide a written summary of my treatment for my doctor at home?
    • How will you communicate with my local doctor, if I want that?
    • What should I do if I have questions or concerns after I return?
    • Who do I contact in an emergency?

    Arrange a plan with a healthcare provider in your home country before you travel, so you know where to go for follow-up.

    Costs: what to clarify

    Costs vary widely and depend on your treatment plan. This guide does not provide prices. Instead, ask for a detailed written estimate that covers:

    • Consultations and monitoring.
    • Laboratory fees and procedures.
    • Medications.
    • Any donor or carrier-related costs, if applicable.
    • Storage fees for embryos or gametes.
    • Administrative or legal fees.
    • What is not included.

    Ask how payments are made, what currency is used, and what the refund policy is if treatment is cancelled or changed.

    Next steps checklist

    1. Clarify your legal situation with a qualified Thai lawyer and check recognition rules in your home country.
    2. Contact several clinics to ask whether they accept patients in your situation.
    3. Request written information on documents, costs, and timelines.
    4. Schedule remote consultations to discuss your questions and assess communication.
    5. Plan travel with flexibility and arrange follow-up care at home.
    6. Keep copies of all documents and correspondence.

    For more general guidance, see our guides, information for international patients, an overview of the treatment process, and additional patient resources.

    Frequently asked questions

    Can same-sex couples get IVF in Thailand?

    Access depends on your specific situation, including your relationship status, nationality, and the type of treatment. Thai law and individual clinic policies vary. You should ask clinics directly whether they currently accept patients in your circumstances and consult a Thai legal professional for advice on parentage and legal recognition.

    What legal considerations should LGBTQ+ patients know about IVF in Thailand?

    Legal considerations may include whether your relationship is recognized, how parentage is established, and what documents are required. Rules can change and may be interpreted differently by clinics. It is important to get independent legal advice and confirm requirements with the clinic before traveling.

    How can I find an inclusive fertility clinic in Thailand?

    Ask clinics about their experience with LGBTQ+ patients, their policies on privacy and communication, and whether they can provide respectful care. Request written information and consider a remote consultation to assess whether the clinic is a good fit for you.

    What should I prepare before traveling to Thailand for IVF?

    Prepare documents such as passports, medical records, and any legal documents the clinic requests. Ask for a written checklist. Also plan for flexible travel dates, accommodation that allows changes, and follow-up care in your home country.

    How do I arrange follow-up care after returning home?

    Before you leave Thailand, ask the clinic for a written summary of your treatment and any recommended follow-up. Arrange a local healthcare provider who can continue your care. Confirm how the clinic will communicate with you and your local doctor if needed.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.